Show simple item record

dc.contributor.authorSánchez, Guillermo
dc.contributor.authorCastro, Carlos
dc.date.accessioned2021-08-25T15:43:59Z
dc.publisherFundación de Otorrinolaringología de Sao Paulospa
dc.description.abstractIntroduction Oral antihistamines and intranasal corticosteroids have been shown to be effective and safe for the treatment of allergic rhinitis; however, the evidence suggests a level of superiority of corticosteroids, so they should be preferred over the former. Objective To know the prescription profile of two second generation antihistamines (cetirizine and levocetirizine) and two nasal corticosteroids (mometasone and furoateciclesonide) in a cohort of patients with allergic rhinitis, and to compare the clinical outcomes obtained. Methods A cohort study was carried including patients with allergic rhinitis treated with cetirizine, levocetirizine, mometasone furoate or ciclesonide. The improvement was evaluated with the total nasal symptoms score (TNSS). This scale yields results between 0 and 12. Zero indicates absence of symptoms. Results A total of 314 patients completed 12 weeks of follow-up. Seventy-five percent were treated with antihistamines, 20% with corticosteroids, and 5% with a combination of the above. The TNSS median for corticosteroid was 2.5 points; for antihistamines, its was 5 points, and for combination, it was 4 points. We found differences between corticosteroids and antihistamines. Conclusion The prescription percentage of second generation oral antihistamines is higher than that of intranasal corticosteroids. However, patients with allergic rhinitis treated with the second option obtained better control of symptoms.eng
dc.date.issued2019-04
dc.sourcehttps://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0039-1688968.pdfspa
dc.format.extent6 p.spa
dc.titlePrescription Profile and Clinical Outcomes in Patients with Allergic Rhinitis Treated with Oral Antihistamines or Nasal Corticosteroidseng
dc.format.mimetypeapplication/pdfspa
dc.typeArtículo de revistaspa
dc.date.available2021-08-25T15:43:59Z
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/1732
dc.language.isoengspa
dc.relation.ispartofInternational archives of otorhinolaryngology e-ISSN:1809-4864 Vol.23 Núm.3 (2019)
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)spa
dc.rights.urihttps://creativecommons.org/licenses/by-nd/4.0/spa
dc.subject.proposalMometasone furoateeng
dc.subject.proposalHistamine antagonistseng
dc.subject.proposalPerennial allergic rhinitiseng
dc.subject.proposalCiclesonideeng
dc.subject.proposalDrug prescriptionseng
dc.subject.proposalCohort studieseng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.subject.decsFuroato de mometasona
dc.subject.decsAntagonistas de los receptores histamínicos
dc.subject.decsRinitis alérgica perenne
dc.subject.decsPrescripciones de medicamentos
dc.subject.decsEstudios de cohortes
dc.publisher.placeBrazilspa
dc.relation.citationendpagee-330spa
dc.relation.citationissue3spa
dc.relation.citationstartpagee-325spa
dc.relation.citationvolume23spa
dc.relation.ispartofjournalInternational archives of otorhinolaryngologyspa
dc.type.contentTextspa
dc.type.redcolhttps://purl.org/redcol/resource_type/WPspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess